XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Operating Expenses        
Research and development $ 2,649 $ 2,339 $ 4,985 $ 3,648
General and administrative 5,864 4,219 10,935 8,167
Depreciation and amortization 160 121 308 236
Total operating expenses and loss from operations 8,673 6,679 16,228 12,051
Other (income) expenses        
Interest income (1,936) 0 (3,768) 0
Interest expense, net of capitalized interest 0 2,560 0 2,839
Change in fair value of derivatives (1,430) 1,035 (596) 1,426
Change in fair value of warrants liability (18,803) (27,265) (17,029) 20,844
Change in fair value of earnout liability (33,188) (45,497) (48,414) (45,497)
Other income, net (247) (43) (698) (623)
Total other (income) expenses, net (55,604) (69,210) (70,505) (21,011)
Net income 46,931 62,531 54,277 8,960
Other comprehensive income (loss)        
Unrealized (loss) on marketable securities (4,805) 0 (9,380) 0
Foreign currency translation adjustment, net of tax (1,693) 626 (808) 1,092
Total comprehensive income $ 40,433 $ 63,157 $ 44,089 $ 10,052
Net income per share, basic (in dollars per share) $ 0.34 $ 0.93 $ 0.40 $ 0.14
Net income per share, diluted (in dollars per share) $ 0.33 $ 0.63 $ 0.38 $ 0.13
Weighted-average common shares outstanding, basic (in shares) 137,141,655 67,548,052 136,985,440 65,098,310
Weighted-average common shares outstanding, diluted (in shares) 142,195,637 78,628,591 142,078,752 70,974,756